Cor Vasa 2010, 52(Suppl.):70-75 | DOI: 10.33678/cor.2010.209

Transcatheter aortic valve implantation (TAVI) using the CoreValve prosthesis - initial experience in Královské Vinohrady University Hospital, advantages and pitfalls of the new method

Viktor Kočka1,*, Petr Widimský1, Petr Toušek1, Pavel Červinka2, František Bednář1, Hana Línková1, Michaela Rýzlová1, Marek Laboš3, Jaroslav Ulman1, Karel Jirásek1, Zbyněk Straka1
1 III. interní-kardiologická klinika, Kardiocentrum, Fakultní nemocnice Královské Vinohrady a 3. lékařská fakulta Univerzity Karlovy, Praha
2 Kardiologické oddělení, Masarykova nemocnice, Ústí nad Labem
3 Radiodiagnostická klinika, Fakultní nemocnice Královské Vinohrady a 3. lékařská fakulta Univerzity Karlovy, Praha, Česká republika

Introduction: Aortic stenosis is the most common type of valvular heart disease in adulthood and transcatheter aortic valve implantation (TAVI) is a new, evolving alternative to standard surgical aortic valve replacement, suitable for high surgical risk patients. We present our initial experience with this method.

Method: The third generation of a self expanding CoreValve Revalving 18 Fr. valve is made up of a nitinol frame and a bioprosthetic valve from the porcine pericardium. We describe the course of the procedure step by step. From April 2009 to January 2010, we performed the TAVI procedure in 17 patients with severe symptomatic aortic stenoses. Brief cohort characteristics are as follows (mean values): age 81 years, logistic EuroSCORE 21%, aortic valve area index 0.42 cm2/m2, left ventricular ejection fraction 52%. The procedural success rate was 100%. Thirty-day mortality was 0% and clinical improvement was obvious, with dyspnea improving by at least one NYHA class in all patients.

Conclusion: Our initial experience with TAVI is most encouraging. Success of TAVI requires a team approach to preoperative assessment, a technically precise procedure and meticulous postoperative care. It is our opinion that a cautious approach to indicating TAVI is needed until its role is confirmed in a longer follow-up; we can expect less selective use of this method in the future.

Keywords: Aortic stenosis; Transcatheter aortic valve implantation

Published: December 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kočka V, Widimský P, Toušek P, Červinka P, Bednář F, Línková H, et al.. Transcatheter aortic valve implantation (TAVI) using the CoreValve prosthesis - initial experience in Královské Vinohrady University Hospital, advantages and pitfalls of the new method. Cor Vasa. 2010;52(Suppl.):70-75. doi: 10.33678/cor.2010.209.
Download citation

References

  1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-1011. Go to original source... Go to PubMed...
  2. Rankin JS, Hammill BG, Ferguson TB, Jr., et al. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 2006;131: 547-557. Go to original source... Go to PubMed...
  3. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243. Go to original source... Go to PubMed...
  4. Kolh P, Kerzmann A, Honore C, et al. Aortic valve surgery in octogenarians: predictive factors for operative and long-term results. Eur J Cardiothorac Surg 2007;31:600-606. Go to original source... Go to PubMed...
  5. Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-2720. Go to original source... Go to PubMed...
  6. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-3008. Go to original source... Go to PubMed...
  7. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616-1624. Go to original source... Go to PubMed...
  8. Osswald BR, Gegouskov V, Badowski-Zyla D, et al. Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 2009;30:74-80. Go to original source... Go to PubMed...
  9. Khawaja MZ, Haworth P, Ghuran A, et al. Transcatheter aortic valve implantation for stenosed and regurgitant aortic valve bioprostheses CoreValve for failed bioprosthetic aortic valve replacements. J Am Coll Cardiol 2010;55:97-101. Go to original source... Go to PubMed...
  10. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463-1470. Go to original source... Go to PubMed...
  11. Del Valle-Fernández R, Martinez CA, Ruiz CE. Transcatheter aortic valve implantation. Cardiol Clin 2010;28:155-168. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.